Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.57 Analyst target: $8.43 Upside: 228.02%
Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.
See the full interactive analysis & chart →Informational only — not investment advice.